T78168 |
NLRP3-IN-17
|
2254432-75-0
|
98%
|
|
NLRP3-IN-17 is a potent, selective, and orally active inhibitor of the NLRP3 inflammasome, demonstrating an IC50 of 7 nM. It effectively inhibits NLRP3-dependent...
|
T78180 |
NLRP3-IN-18
|
2769040-06-2
|
98%
|
|
NLRP3-IN-18, also known as compound 13, is a potent inhibitor of NLRP3, demonstrating an IC50 value of ≤1.0 µM [1].
|
T78613 |
Selnoflast calcium
|
2887416-19-3
|
98%
|
|
Selnoflast calcium (example 6), an NLRP3 inhibitor (extracted from patent WO2019008025) [1], is a chemical compound designed to suppress the activity of the NLRP...
|
T78614 |
Selnoflast potassium
|
|
98%
|
|
Selnoflast (potassium) (example 6), is an NLRP3 inhibitor.
|
T78822 |
JT002
|
2238820-43-2
|
98%
|
|
JT002 is an orally active NLRP3 inflammasome inhibitor that decreases the production of NLRP3-dependent proinflammatory cytokines (such as IL-1β, IL-1α, IL-18) a...
|
T78894 |
NLRP3-IN-21
|
2956791-61-8
|
98%
|
|
NLRP3-IN-21 (compound L38) is an inhibitor of the NLRP3 inflammasome that possesses anti-inflammatory properties. It suppresses the activation of the NLRP3 infla...
|
T79446 |
INF200
|
|
98%
|
|
INF200 (compound 5), a sulfonylurea-based inhibitor of NLRP3 and associated pyroptosis, exhibits cardiometabolic benefits in a rat model of high-fat diet (HFD)-i...
|
T79590 |
Anti-neuroinflammation agent 1
|
|
98%
|
|
Anti-neuroinflammation Agent 1 effectively modulates BV2 microglia cell polarization, shifting from an M1 to an M2 phenotype [1].
|
T79695 |
NLRP3-IN-19
|
2238819-65-1
|
98%
|
|
JT001 (NLRP3-IN-19) is a potent, specific, and orally active NLRP3 inhibitor that impedes the assembly of the NLRP3 inflammasome. This action results in the supp...
|
T79696 |
JT001 sodium
|
|
98%
|
|
JT001 (NLRP3-IN-19) sodium is a potent, specific, and orally active NLRP3 inhibitor that impedes the assembly of the NLRP3 inflammasome, thus curbing cytokine re...
|
T79733 |
NLRP3-IN-20
|
2428478-22-0
|
98%
|
|
NLRP3-IN-20 (compound 11) is an orally administered inhibitor targeting the NLRP3 inflammasome, exhibiting potent inhibition with an IC50 of 25 nM against IL-1β ...
|
T79864 |
Usnoflast
|
2455519-86-3
|
98%
|
|
Usnoflast functions as an NLRP3 modulator and also serves as a non-steroidal anti-inflammatory agent (NSAID) [1].
|
T80267 |
TriDAP
|
877462-71-0
|
98%
|
|
TriDAP (L-Ala-γ-D-Glu-meso-diaminopimelic acid), a biologically active peptide, functions as a specific Nod1 activator.
|
T80268 |
IE-DAP
|
592520-07-5
|
98%
|
|
iE-DAP is a biologically active peptide that functions as a NOD1 agonist.
|
T80273 |
M-TriDAP
|
60230-21-9
|
98%
|
|
M-TriDAP (N-Acetylmuramyl-L-Ala-γ-D-Glu-meso-diaminopimelic acid) is a bioactive peptide functioning as a NOD1/2 agonist.
|
T81637 |
NT-0796
|
2272917-13-0
|
98%
|
|
NT-0796, a selective CNS-penetrant NLRP3 inflammasome inhibitor, exhibits potent inhibitory activity with an IC50 of 0.32 nM in PBMC assays. As an isopropyl este...
|
T81665 |
NLRP3-IN-23
|
|
98%
|
|
NLRP3-IN-23 (Compound 15C) is an inhibitor that significantly impedes heme-mediated activation of the NLRP3 inflammasome at a concentration of 0.1 μM [1].
|
T81666 |
NLRP3-IN-22
|
1193329-98-4
|
98%
|
|
NLRP3-IN-22 (Compound II-4) is an inhibitor of NLRP3, exhibiting a 67% inhibition rate at a concentration of 10 μM [1].
|
T81667 |
NLRP3 agonist 2
|
|
98%
|
|
NLRP3 agonist 2 (compound 22) is an orally active agent that activates Caspase-1 in THP1 cells [1].
|
T81668 |
NLRP3 agonist 1
|
2454019-69-1
|
98%
|
|
NLRP3 agonist 1 (compound 23) serves as a potent, orally active agent that activates Caspase-1 enzyme, leading to the cleavage of proinflammatory cytokines pro-I...
|